Shi Zhengzheng
Partner @ Yingke Capital
Fuzhou, China
Shi Zhengzheng is a seed investor at Yingke Capital in Fuzhou focused on Biotechnology and Genetics. Shi Zhengzheng working as a partner of Yingke Capital.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Shi Zhengzheng invests in
Stages Shi Zhengzheng invests in
Countries Shi Zhengzheng invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- Genetics 1 (50%)
- Health Care 1 (50%)
Stage
- Seed 1 (50%)
- Series C 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Gene Vector
|
Chengdu Genevector Biotechnology Co., Ltd. (Genevector, Genevector) is a biotechnology company engaged in the research and development of new drugs for adeno-associated virus (AAV) gene therapy. The company is committed to the development of new AAV gene therapy drugs for ophthalmic diseases, neuromuscular diseases, genetic and metabolic diseases,etc. | $3.2M / Seed / Mar 10, 2022 | |
Hrain Biotechnology
|
Hrain Biotechnology is a tumor immunotherapy technology developer, using the tumor immunotherapy technology CAR-T to provide cancer patients with precise treatment based on biological and cellular technology, and built centers in Beijing, Jiangsu, Chongqing, Henan and other places. Clinical trial platform. | Series C / Apr 26, 2021 |
Co-Investors
About Yingke Capital
Yingke Capital is a principal investment firm specializing in pre-IPO investments. It seeks to invest in 5G internet of things, biomedical, environmental and facilities services, new energy, consumer upgrade, smart manufacturing and materials sector. Yingke Capital prefers to invest in companies with high technology R&D and productioncapacity. Mingfei Qian founded it in 2010, with its headquarters in Fuzhou in China.
Yingke Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Chen Yulei
Chief Investment Officer
|
|||
Manying Lai
President
|
|||
|
Shi Zhengzheng
Partner
|
|||
Shuqing Wu
President of Financial Division
|
|||
Xiaochen Zhou
Vice-President
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Shi Zhengzheng invest in?
Shi Zhengzheng invests primarily in Biotechnology, Genetics and Health Care startups, most often at Seed and Series C stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Shi Zhengzheng last invest?
The most recent investment recorded for Shi Zhengzheng closed in Mar 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
